InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
Product | Citation | Year | Journal | Authors | Page |
---|---|---|---|---|---|
Blasticidin | A therapeutically targetable positive feedback loop between lnc-HLX-2-7, HLX,... | 2024 | Cell Rep. | Katsushima K. et al. | DOI: 10.1016/j.celrep.2024.113938 |
Puromycin | A therapeutically targetable positive feedback loop between lnc-HLX-2-7, HLX,... | 2024 | Cell Rep. | Katsushima K. et al. | DOI: 10.1016/j.celrep.2024.113938 |
MycoStrip® - Mycoplasma Detection Kit | MARCH2, a novel oncogene-regulated SNAIL E3 ligase, suppresses triple negativ... | 2024 | Cancer Res Commun. | Ito K. et al. | DOI: 10.1158/2767-9764.CRC-23-0090 |
Puromycin | Neutralizing immunity against coronaviruses in Tanzanian health care workers. | 2024 | Sci Rep. | Barabona G. et al. | DOI: 10.1038/s41598-024-55989-4 |
Nigericin | Protocol to measure apoptosis-associated speck-like protein containing a CARD... | 2024 | STAR Protoc. | Sánchez K.E. et al. | DOI: 10.1016/j.xpro.2024.102916 |
RU.521 | DNA corona on nanoparticles leads to an enhanced immunostimulatory effect wit... | 2024 | PNAS | Anees F. et al. | DOI: 10.1073/pnas.2319634121 |
STING inhibitor | DNA corona on nanoparticles leads to an enhanced immunostimulatory effect wit... | 2024 | PNAS | Anees F. et al. | DOI: 10.1073/pnas.2319634121 |
ODN 2088 | DNA corona on nanoparticles leads to an enhanced immunostimulatory effect wit... | 2024 | PNAS | Anees F. et al. | DOI: 10.1073/pnas.2319634121 |
Primocin® | Changes in chromatin accessibility and transcriptional landscape induced by H... | 2024 | Biomed Pharmacother. | Gagliano T. et al. | DOI: 10.1016/j.biopha.2024.116374 |
Primocin® | Single-cell guided prenatal derivation of primary fetal epithelial organoids ... | 2024 | Nat Med. | Gerli M.F.M. et al. | DOI: 10.1038/s41591-024-02807-z |
Normocin® - Antimicrobial Reagent | Overcoming doxorubicin resistance in triple-negative breast cancer using the ... | 2024 | Breast Cancer Res. | Smoots S.G. et al. | DOI: 10.1186/s13058-024-01799-5 |
R848 (Resiquimod) | Protocol for localized macrophage stimulation with small-molecule TLR agonist... | 2024 | STAR Protoc. | Mulder E.J. et al. | DOI: 10.1016/j.xpro.2024.102873 |
MycoStrip® - Mycoplasma Detection Kit | The host-targeted antiviral drug Zapnometinib exhibits a high barrier to the ... | 2024 | Antiviral Res. | Schreiber A. et al. | DOI: 10.1016/j.antiviral.2024.105840 |
eSEAP | Rational design of an artificial tethered enzyme for non-templated post-trans... | 2024 | Sci Rep. | Le Boulch M. et al. | DOI: 10.1038/s41598-024-55947-0 |
QUANTI-Blue™ | Rational design of an artificial tethered enzyme for non-templated post-trans... | 2024 | Sci Rep. | Le Boulch M. et al. | DOI: 10.1038/s41598-024-55947-0 |
OVA peptides | Targeted deletion of CD244 on monocytes promotes differentiation into anti-tu... | 2024 | Mol Cancer | Kim J. et al. | DOI: 10.1186/s12943-024-01936-w |
OVA protein | Targeted deletion of CD244 on monocytes promotes differentiation into anti-tu... | 2024 | Mol Cancer | Kim J. et al. | DOI: 10.1186/s12943-024-01936-w |
Pam3CSK4 | Hyperglycaemia amplifies TLR-mediated inflammatory response of M(IL4) macroph... | 2024 | J Leukoc Biol. | Badillo-Garcia L.E. et al. | DOI: 10.1093/jleuko/qiae050 |
LPS-EB (LPS from E. coli O111:B4) | Hyperglycaemia amplifies TLR-mediated inflammatory response of M(IL4) macroph... | 2024 | J Leukoc Biol. | Badillo-Garcia L.E. et al. | DOI: 10.1093/jleuko/qiae050 |
LPS-EB VacciGrade™ | Elevated CD169 expressing monocyte/macrophage promotes systemic inflammation ... | 2024 | Clin Exp Med. | Xu L. et al. | DOI: 10.1007/s10238-024-01305-3 |